Core Viewpoint - The company, Hefei China, anticipates a significant net loss for the year 2025, with projected losses ranging from 25 million to 36 million yuan for net profit attributable to shareholders, and from 24 million to 35 million yuan for net profit after excluding non-recurring gains and losses [1] Group 1: Financial Performance - The expected net loss for 2025 is between 25 million and 36 million yuan [1] - The projected net profit after excluding non-recurring items is estimated to be between 24 million and 35 million yuan [1] Group 2: Reasons for Performance - The primary reasons for the anticipated losses include changes in the domestic macro environment and the impact of centralized procurement policies in the in-vitro diagnostic industry, leading to decreased product procurement prices and fluctuations in order volumes [1] - Despite cost-saving measures, fixed expenditures could not be proportionately reduced alongside income, and investments in talent optimization and capability upgrades contributed to the expected losses [1] - The company is actively adjusting its business layout and development strategy, focusing on the technological iteration and innovation of its proprietary "ACME" products, increasing R&D investments, and expanding its market development team [1]
合富中国:预计2025年全年净亏损2500万元—3600万元